On March 28, 2023, Torii Pharmaceutical Co., Ltd. held its Extraordinary General Meeting of Shareholders and according to the results, the proposals by LIM Advisors Limited on Appropriation of Surplus, Acquisition of Treasury Stock, Partial Amendment to Articles of Incorporation regarding Disclosure of compensation of directors with representation rights and regarding Disclosure of results of fund management review through CMS were rejected.